|
erythrocyte homeostasis
|
GO:0034101 |
55 |
0.772
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
191 |
0.632
|
|
|
hemopoiesis
|
GO:0030097 |
183 |
0.622
|
|
|
erythrocyte maturation
|
GO:0043249 |
8 |
0.463
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
3 |
0.448
|
|
|
immune system process
|
GO:0002376 |
241 |
0.416
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
56 |
0.372
|
|
|
myeloid cell differentiation
|
GO:0030099 |
86 |
0.354
|
|
|
regulation of biosynthetic process
|
GO:0009889 |
250 |
0.300
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
3 |
0.275
|
|
|
erythrocyte differentiation
|
GO:0030218 |
54 |
0.260
|
|
|
organic cyclic compound metabolic process
|
GO:1901360 |
301 |
0.234
|
|
|
immune system development
|
GO:0002520 |
191 |
0.226
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
1 |
0.215
|
|
|
cellular macromolecule biosynthetic process
|
GO:0034645 |
224 |
0.191
|
|
|
cellular response to chemical stimulus
|
GO:0070887 |
157 |
0.185
|
|
|
signal transduction
|
GO:0007165 |
455 |
0.184
|
|
|
regulation of cellular biosynthetic process
|
GO:0031326 |
245 |
0.176
|
|
|
heterocycle biosynthetic process
|
GO:0018130 |
215 |
0.176
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
3 |
0.174
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
2 |
0.165
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
2 |
0.160
|
|
|
cellular amide metabolic process
|
GO:0043603 |
4 |
0.151
|
|
|
cellular nitrogen compound biosynthetic process
|
GO:0044271 |
218 |
0.151
|
|
|
response to external stimulus
|
GO:0009605 |
264 |
0.146
|
|
|
regulation of primary metabolic process
|
GO:0080090 |
311 |
0.144
|
|
|
aromatic compound biosynthetic process
|
GO:0019438 |
217 |
0.142
|
|
|
lateral line development
|
GO:0048882 |
66 |
0.141
|
|
|
heterocycle metabolic process
|
GO:0046483 |
290 |
0.136
|
|
|
regulation of cellular metabolic process
|
GO:0031323 |
320 |
0.134
|
|
|
porphyrin containing compound biosynthetic process
|
GO:0006779 |
8 |
0.127
|
|
|
cellular transition metal ion homeostasis
|
GO:0046916 |
3 |
0.127
|
|
|
organic substance biosynthetic process
|
GO:1901576 |
289 |
0.126
|
|
|
cell surface receptor signaling pathway
|
GO:0007166 |
325 |
0.123
|
|
|
cellular macromolecule metabolic process
|
GO:0044260 |
391 |
0.119
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
4 |
0.116
|
|
|
single organism metabolic process
|
GO:0044710 |
217 |
0.111
|
|
|
response to bacterium
|
GO:0009617 |
58 |
0.111
|
|
|
specification of symmetry
|
GO:0009799 |
204 |
0.109
|
|
|
rna metabolic process
|
GO:0016070 |
219 |
0.108
|
|
|
cellular nitrogen compound metabolic process
|
GO:0034641 |
290 |
0.106
|
|
|
nucleic acid metabolic process
|
GO:0090304 |
244 |
0.103
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
1 |
0.103
|
|
|
protein metabolic process
|
GO:0019538 |
183 |
0.099
|
|
|
embryonic organ development
|
GO:0048568 |
381 |
0.099
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
55 |
0.097
|
|
|
regulation of nucleic acid templated transcription
|
GO:1903506 |
213 |
0.094
|
|
|
heart morphogenesis
|
GO:0003007 |
156 |
0.094
|
|
|
cellular biosynthetic process
|
GO:0044249 |
286 |
0.092
|
|
|
chemical homeostasis
|
GO:0048878 |
49 |
0.091
|
|
|
response to other organism
|
GO:0051707 |
97 |
0.090
|
|
|
regulation of gene expression
|
GO:0010468 |
265 |
0.090
|
|
|
regulation of rna biosynthetic process
|
GO:2001141 |
213 |
0.087
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
23 |
0.086
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
5 |
0.085
|
|
|
primitive erythrocyte differentiation
|
GO:0060319 |
5 |
0.083
|
|
|
transcription dna templated
|
GO:0006351 |
181 |
0.083
|
|
|
cellular aromatic compound metabolic process
|
GO:0006725 |
295 |
0.083
|
|
|
regulation of metabolic process
|
GO:0019222 |
359 |
0.083
|
|
|
leukocyte proliferation
|
GO:0070661 |
1 |
0.082
|
|
|
mononuclear cell proliferation
|
GO:0032943 |
1 |
0.081
|
|
|
single organism localization
|
GO:1902578 |
225 |
0.080
|
|
|
iron ion homeostasis
|
GO:0055072 |
4 |
0.080
|
|
|
erythrocyte development
|
GO:0048821 |
24 |
0.079
|
|
|
regulation of macromolecule metabolic process
|
GO:0060255 |
317 |
0.077
|
|
|
tube morphogenesis
|
GO:0035239 |
349 |
0.076
|
|
|
homeostasis of number of cells
|
GO:0048872 |
62 |
0.074
|
|
|
definitive hemopoiesis
|
GO:0060216 |
18 |
0.074
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
1 |
0.074
|
|
|
otic placode formation
|
GO:0043049 |
23 |
0.073
|
|
|
organic cyclic compound biosynthetic process
|
GO:1901362 |
223 |
0.073
|
|
|
macromolecule biosynthetic process
|
GO:0009059 |
227 |
0.073
|
|
|
leukocyte differentiation
|
GO:0002521 |
25 |
0.071
|
|
|
nitrogen compound metabolic process
|
GO:0006807 |
319 |
0.071
|
|
|
nucleobase containing compound biosynthetic process
|
GO:0034654 |
205 |
0.069
|
|
|
regulation of nitrogen compound metabolic process
|
GO:0051171 |
251 |
0.066
|
|
|
cellular response to external stimulus
|
GO:0071496 |
2 |
0.065
|
|
|
positive regulation of transport
|
GO:0051050 |
2 |
0.064
|
|
|
osteoclast differentiation
|
GO:0030316 |
1 |
0.064
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
2 |
0.061
|
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
45 |
0.061
|
|
|
ectodermal placode morphogenesis
|
GO:0071697 |
32 |
0.061
|
|
|
regulation of cytokine production
|
GO:0001817 |
3 |
0.060
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
74 |
0.059
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
56 |
0.059
|
|
|
cellular iron ion homeostasis
|
GO:0006879 |
3 |
0.059
|
|
|
single fertilization
|
GO:0007338 |
3 |
0.057
|
|
|
central nervous system development
|
GO:0007417 |
387 |
0.057
|
|
|
homeostatic process
|
GO:0042592 |
142 |
0.056
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
80 |
0.056
|
|
|
nuclear transcribed mrna catabolic process nonsense mediated decay
|
GO:0000184 |
4 |
0.055
|
|
|
regulation of macromolecule biosynthetic process
|
GO:0010556 |
225 |
0.055
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
15 |
0.054
|
|
|
larval development
|
GO:0002164 |
2 |
0.054
|
|
|
lymphocyte proliferation
|
GO:0046651 |
1 |
0.054
|
|
|
metal ion homeostasis
|
GO:0055065 |
26 |
0.053
|
|
|
regionalization
|
GO:0003002 |
274 |
0.053
|
|
|
peptide metabolic process
|
GO:0006518 |
1 |
0.053
|
|
|
translational initiation
|
GO:0006413 |
3 |
0.052
|
|
|
otic vesicle morphogenesis
|
GO:0071600 |
34 |
0.052
|
|
|
gene expression
|
GO:0010467 |
252 |
0.052
|
|
|
determination of bilateral symmetry
|
GO:0009855 |
204 |
0.052
|
|
|
stem cell proliferation
|
GO:0072089 |
4 |
0.051
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
1 |
0.051
|
|
|
response to biotic stimulus
|
GO:0009607 |
97 |
0.050
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
47 |
0.049
|
|
|
biosynthetic process
|
GO:0009058 |
294 |
0.049
|
|
|
regulation of biological quality
|
GO:0065008 |
263 |
0.048
|
|
|
response to organic substance
|
GO:0010033 |
153 |
0.048
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
1 |
0.047
|
|
|
phagocytosis
|
GO:0006909 |
3 |
0.047
|
|
|
nucleic acid templated transcription
|
GO:0097659 |
181 |
0.047
|
|
|
single organism biosynthetic process
|
GO:0044711 |
71 |
0.046
|
|
|
regulation of transcription dna templated
|
GO:0006355 |
213 |
0.046
|
|
|
neuron fate determination
|
GO:0048664 |
2 |
0.046
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
1 |
0.046
|
|
|
response to carbohydrate
|
GO:0009743 |
3 |
0.046
|
|
|
posterior lateral line development
|
GO:0048916 |
38 |
0.046
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
2 |
0.045
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
106 |
0.045
|
|
|
transport
|
GO:0006810 |
220 |
0.045
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
148 |
0.044
|
|
|
iron ion transport
|
GO:0006826 |
4 |
0.044
|
|
|
heart looping
|
GO:0001947 |
94 |
0.043
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
9 |
0.042
|
|
|
antimicrobial humoral response
|
GO:0019730 |
2 |
0.042
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
11 |
0.042
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
69 |
0.042
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
274 |
0.041
|
|
|
primitive hemopoiesis
|
GO:0060215 |
27 |
0.041
|
|
|
regulation of cellular macromolecule biosynthetic process
|
GO:2000112 |
222 |
0.040
|
|
|
apoptotic process
|
GO:0006915 |
116 |
0.040
|
|
|
ectodermal placode development
|
GO:0071696 |
37 |
0.040
|
|
|
protein modification process
|
GO:0036211 |
100 |
0.039
|
|
|
myeloid cell development
|
GO:0061515 |
32 |
0.039
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
4 |
0.039
|
|
|
heme metabolic process
|
GO:0042168 |
9 |
0.038
|
|
|
regulation of nucleobase containing compound metabolic process
|
GO:0019219 |
250 |
0.038
|
|
|
ion homeostasis
|
GO:0050801 |
41 |
0.037
|
|
|
cellular protein metabolic process
|
GO:0044267 |
129 |
0.036
|
|
|
maintenance of location
|
GO:0051235 |
4 |
0.036
|
|
|
aging
|
GO:0007568 |
2 |
0.036
|
|
|
regulation of cell activation
|
GO:0050865 |
1 |
0.035
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
117 |
0.035
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
93 |
0.035
|
|
|
negative regulation of gene expression
|
GO:0010629 |
65 |
0.035
|
|
|
cation homeostasis
|
GO:0055080 |
33 |
0.034
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
0 |
0.034
|
|
|
oxoacid metabolic process
|
GO:0043436 |
31 |
0.034
|
|
|
response to stress
|
GO:0006950 |
263 |
0.034
|
|
|
eye development
|
GO:0001654 |
277 |
0.034
|
|
|
multi organism process
|
GO:0051704 |
134 |
0.033
|
|
|
heart process
|
GO:0003015 |
71 |
0.033
|
|
|
compound eye development
|
GO:0048749 |
2 |
0.033
|
|
|
response to external biotic stimulus
|
GO:0043207 |
97 |
0.033
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
2 |
0.032
|
|
|
regulation of cell communication
|
GO:0010646 |
232 |
0.032
|
|
|
cellular response to lipid
|
GO:0071396 |
39 |
0.032
|
|
|
cellular cation homeostasis
|
GO:0030003 |
17 |
0.032
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
5 |
0.031
|
|
|
regulation of wound healing
|
GO:0061041 |
2 |
0.031
|
|
|
cellular response to starvation
|
GO:0009267 |
1 |
0.031
|
|
|
small molecule metabolic process
|
GO:0044281 |
77 |
0.031
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
68 |
0.030
|
|
|
amide biosynthetic process
|
GO:0043604 |
1 |
0.030
|
|
|
cardiac chamber formation
|
GO:0003207 |
4 |
0.030
|
|
|
inner ear development
|
GO:0048839 |
126 |
0.030
|
|
|
intestinal absorption
|
GO:0050892 |
2 |
0.030
|
|
|
fin development
|
GO:0033333 |
77 |
0.030
|
|
|
regulation of binding
|
GO:0051098 |
3 |
0.030
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
59 |
0.030
|
|
|
positive regulation of stress activated protein kinase signaling cascade
|
GO:0070304 |
3 |
0.029
|
|
|
otic vesicle development
|
GO:0071599 |
42 |
0.029
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
1 |
0.029
|
|
|
inner ear morphogenesis
|
GO:0042472 |
63 |
0.028
|
|
|
neuromast primordium migration
|
GO:0048883 |
12 |
0.028
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
3 |
0.027
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
1 |
0.027
|
|
|
rna biosynthetic process
|
GO:0032774 |
181 |
0.027
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
3 |
0.027
|
|
|
single organism transport
|
GO:0044765 |
206 |
0.027
|
|
|
death
|
GO:0016265 |
121 |
0.027
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
2 |
0.027
|
|
|
negative regulation of macromolecule metabolic process
|
GO:0010605 |
76 |
0.026
|
|
|
lymphatic endothelial cell differentiation
|
GO:0060836 |
1 |
0.026
|
|
|
liver development
|
GO:0001889 |
96 |
0.026
|
|
|
response to uv
|
GO:0009411 |
3 |
0.026
|
|
|
embryonic digestive tract development
|
GO:0048566 |
4 |
0.025
|
|
|
connective tissue development
|
GO:0061448 |
99 |
0.025
|
|
|
lymphatic endothelial cell fate commitment
|
GO:0060838 |
1 |
0.025
|
|
|
vasculature development
|
GO:0001944 |
278 |
0.025
|
|
|
lipid storage
|
GO:0019915 |
1 |
0.025
|
|
|
regulation of programmed cell death
|
GO:0043067 |
101 |
0.025
|
|
|
regulation of multicellular organismal process
|
GO:0051239 |
277 |
0.024
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
7 |
0.024
|
|
|
regulation of rna metabolic process
|
GO:0051252 |
224 |
0.024
|
|
|
cytokine metabolic process
|
GO:0042107 |
1 |
0.024
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
7 |
0.024
|
|
|
regulation of sequestering of calcium ion
|
GO:0051282 |
4 |
0.024
|
|
|
embryonic neurocranium morphogenesis
|
GO:0048702 |
15 |
0.024
|
|
|
regulation of developmental process
|
GO:0050793 |
247 |
0.024
|
|
|
regulation of translation
|
GO:0006417 |
3 |
0.023
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
14 |
0.023
|
|
|
nuclear transport
|
GO:0051169 |
4 |
0.023
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
3 |
0.023
|
|
|
type i interferon production
|
GO:0032606 |
2 |
0.023
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
2 |
0.023
|
|
|
membrane hyperpolarization
|
GO:0060081 |
1 |
0.023
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
3 |
0.023
|
|
|
response to glucocorticoid
|
GO:0051384 |
1 |
0.022
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
90 |
0.022
|
|
|
generation of neurons
|
GO:0048699 |
385 |
0.022
|
|
|
ear morphogenesis
|
GO:0042471 |
64 |
0.022
|
|
|
regulation of cell death
|
GO:0010941 |
103 |
0.022
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
48 |
0.021
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
2 |
0.021
|
|
|
response to lipid
|
GO:0033993 |
60 |
0.021
|
|
|
tissue remodeling
|
GO:0048771 |
4 |
0.021
|
|
|
cell migration
|
GO:0016477 |
237 |
0.021
|
|
|
regulation of immune effector process
|
GO:0002697 |
5 |
0.021
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
114 |
0.021
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
1 |
0.021
|
|
|
response to amine
|
GO:0014075 |
1 |
0.021
|
|
|
determination of left right symmetry
|
GO:0007368 |
179 |
0.020
|
|
|
regulation of cellular protein metabolic process
|
GO:0032268 |
52 |
0.020
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
1 |
0.020
|
|
|
cartilage development
|
GO:0051216 |
96 |
0.020
|
|
|
gtp metabolic process
|
GO:0046039 |
4 |
0.020
|
|
|
lateral line system development
|
GO:0048925 |
76 |
0.020
|
|
|
protein localization to nucleus
|
GO:0034504 |
3 |
0.020
|
|
|
hepaticobiliary system development
|
GO:0061008 |
98 |
0.020
|
|
|
regulation of heart growth
|
GO:0060420 |
2 |
0.020
|
|
|
digestive system process
|
GO:0022600 |
9 |
0.020
|
|
|
astrocyte differentiation
|
GO:0048708 |
1 |
0.020
|
|
|
retina development in camera type eye
|
GO:0060041 |
146 |
0.020
|
|
|
regulation of signaling
|
GO:0023051 |
235 |
0.020
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
3 |
0.019
|
|
|
peptide transport
|
GO:0015833 |
1 |
0.019
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
2 |
0.019
|
|
|
locomotion
|
GO:0040011 |
313 |
0.019
|
|
|
cardiac chamber development
|
GO:0003205 |
19 |
0.019
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
0 |
0.019
|
|
|
hormone secretion
|
GO:0046879 |
2 |
0.019
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
2 |
0.019
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
3 |
0.019
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
57 |
0.019
|
|
|
translation
|
GO:0006412 |
5 |
0.019
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
52 |
0.018
|
|
|
epithelial cell differentiation
|
GO:0030855 |
116 |
0.018
|
|
|
embryonic heart tube development
|
GO:0035050 |
133 |
0.018
|
|
|
dorsal ventral pattern formation
|
GO:0009953 |
125 |
0.018
|
|
|
b cell activation
|
GO:0042113 |
2 |
0.018
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
8 |
0.018
|
|
|
regulation of translational initiation
|
GO:0006446 |
1 |
0.018
|
|
|
respiratory burst
|
GO:0045730 |
2 |
0.018
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
68 |
0.017
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
5 |
0.017
|
|
|
ventricular cardiac muscle cell differentiation
|
GO:0055012 |
6 |
0.017
|
|
|
regulation of signal transduction
|
GO:0009966 |
225 |
0.017
|
|
|
regulation of bone remodeling
|
GO:0046850 |
2 |
0.017
|
|
|
cellular response to organic substance
|
GO:0071310 |
105 |
0.017
|
|
|
skeletal system development
|
GO:0001501 |
181 |
0.017
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
3 |
0.017
|
|
|
cellular protein modification process
|
GO:0006464 |
100 |
0.017
|
|
|
embryonic pectoral fin morphogenesis
|
GO:0035118 |
24 |
0.017
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
59 |
0.017
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
1 |
0.017
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
2 |
0.017
|
|
|
cell death
|
GO:0008219 |
121 |
0.017
|
|
|
heart valve formation
|
GO:0003188 |
4 |
0.016
|
|
|
stem cell maintenance
|
GO:0019827 |
4 |
0.016
|
|
|
protein targeting to nucleus
|
GO:0044744 |
3 |
0.016
|
|
|
granulocyte differentiation
|
GO:0030851 |
8 |
0.016
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
5 |
0.016
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
13 |
0.016
|
|
|
regulation of response to stimulus
|
GO:0048583 |
269 |
0.016
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
152 |
0.016
|
|
|
programmed cell death
|
GO:0012501 |
119 |
0.016
|
|
|
response to endogenous stimulus
|
GO:0009719 |
83 |
0.016
|
|
|
peripheral nervous system development
|
GO:0007422 |
55 |
0.016
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
4 |
0.016
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
1 |
0.016
|
|
|
sensory system development
|
GO:0048880 |
76 |
0.016
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
2 |
0.016
|
|
|
multicellular organism growth
|
GO:0035264 |
4 |
0.016
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
0 |
0.016
|
|
|
regulation of protein transport
|
GO:0051223 |
3 |
0.016
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
53 |
0.015
|
|
|
appendage development
|
GO:0048736 |
80 |
0.015
|
|
|
neuromast development
|
GO:0048884 |
46 |
0.015
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
48 |
0.015
|
|
|
sensory organ development
|
GO:0007423 |
393 |
0.015
|
|
|
interferon beta production
|
GO:0032608 |
1 |
0.015
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
1 |
0.015
|
|
|
cellular ion homeostasis
|
GO:0006873 |
17 |
0.015
|
|
|
negative regulation of nuclear division
|
GO:0051784 |
3 |
0.015
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
108 |
0.015
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
1 |
0.015
|
|
|
regulation of neurotransmitter transport
|
GO:0051588 |
1 |
0.015
|
|
|
organic acid metabolic process
|
GO:0006082 |
31 |
0.015
|
|
|
negative regulation of cellular process
|
GO:0048523 |
283 |
0.015
|
|
|
sequestering of metal ion
|
GO:0051238 |
3 |
0.015
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
79 |
0.015
|
|
|
cellular response to stress
|
GO:0033554 |
62 |
0.015
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
1 |
0.015
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
0 |
0.015
|
|
|
negative regulation of biological process
|
GO:0048519 |
304 |
0.015
|
|
|
b cell mediated immunity
|
GO:0019724 |
3 |
0.015
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
2 |
0.014
|
|
|
retinoic acid receptor signaling pathway
|
GO:0048384 |
16 |
0.014
|
|
|
system process
|
GO:0003008 |
185 |
0.014
|
|
|
cellular response to retinoic acid
|
GO:0071300 |
1 |
0.014
|
|
|
endothelial cell fate commitment
|
GO:0060839 |
3 |
0.014
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
8 |
0.014
|
|
|
defense response
|
GO:0006952 |
47 |
0.014
|
|
|
atrioventricular valve formation
|
GO:0003190 |
3 |
0.014
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
2 |
0.014
|
|
|
neurotransmitter secretion
|
GO:0007269 |
2 |
0.014
|
|
|
transition metal ion transport
|
GO:0000041 |
6 |
0.014
|
|
|
regulation of blood coagulation
|
GO:0030193 |
1 |
0.014
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
59 |
0.014
|
|
|
nuclear import
|
GO:0051170 |
3 |
0.014
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
3 |
0.014
|
|
|
positive regulation of wound healing
|
GO:0090303 |
1 |
0.014
|
|
|
autophagy
|
GO:0006914 |
4 |
0.014
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
55 |
0.014
|
|
|
negative regulation of mitosis
|
GO:0045839 |
3 |
0.014
|
|
|
cell projection organization
|
GO:0030030 |
284 |
0.014
|
|
|
single organism nuclear import
|
GO:1902593 |
3 |
0.014
|
|
|
positive regulation of translation
|
GO:0045727 |
1 |
0.013
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
4 |
0.013
|
|
|
activation of innate immune response
|
GO:0002218 |
6 |
0.013
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
4 |
0.013
|
|
|
cardiac atrium development
|
GO:0003230 |
4 |
0.013
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
3 |
0.013
|
|
|
regulation of myelination
|
GO:0031641 |
1 |
0.013
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
2 |
0.013
|
|
|
rhombomere 5 development
|
GO:0021571 |
4 |
0.013
|
|
|
regulation of protein binding
|
GO:0043393 |
3 |
0.013
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
69 |
0.013
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
1 |
0.013
|
|
|
phosphorus metabolic process
|
GO:0006793 |
109 |
0.013
|
|
|
mechanosensory lateral line system development
|
GO:0048881 |
49 |
0.013
|
|
|
positive regulation of type i interferon production
|
GO:0032481 |
1 |
0.013
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
4 |
0.013
|
|
|
ear development
|
GO:0043583 |
127 |
0.013
|
|
|
regulation of protein targeting
|
GO:1903533 |
2 |
0.013
|
|
|
endocardium formation
|
GO:0060214 |
1 |
0.013
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
58 |
0.013
|
|
|
neurotransmitter transport
|
GO:0006836 |
2 |
0.013
|
|
|
lymph vessel morphogenesis
|
GO:0036303 |
25 |
0.013
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
31 |
0.013
|
|
|
pectoral fin development
|
GO:0033339 |
50 |
0.013
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
77 |
0.013
|
|
|
midbrain development
|
GO:0030901 |
28 |
0.012
|
|
|
embryonic skeletal system development
|
GO:0048706 |
97 |
0.012
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
4 |
0.012
|
|
|
mitochondrion organization
|
GO:0007005 |
4 |
0.012
|
|
|
calcium ion homeostasis
|
GO:0055074 |
19 |
0.012
|
|
|
regulation of reproductive process
|
GO:2000241 |
4 |
0.012
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
2 |
0.012
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
1 |
0.012
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
4 |
0.012
|
|
|
ribosomal small subunit biogenesis
|
GO:0042274 |
2 |
0.012
|
|
|
endocardium morphogenesis
|
GO:0003160 |
4 |
0.012
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
4 |
0.012
|
|
|
positive regulation of cellular metabolic process
|
GO:0031325 |
94 |
0.012
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
29 |
0.012
|
|
|
negative regulation of myeloid leukocyte differentiation
|
GO:0002762 |
1 |
0.012
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
3 |
0.012
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.012
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
50 |
0.012
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
3 |
0.012
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
3 |
0.012
|
|
|
response to corticosteroid
|
GO:0031960 |
1 |
0.012
|
|
|
regulation of apoptotic process
|
GO:0042981 |
98 |
0.012
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
80 |
0.012
|
|
|
negative regulation of cell death
|
GO:0060548 |
60 |
0.012
|
|
|
otic vesicle formation
|
GO:0030916 |
27 |
0.012
|
|
|
cardiac ventricle development
|
GO:0003231 |
9 |
0.012
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
2 |
0.012
|
|
|
negative regulation of rna metabolic process
|
GO:0051253 |
48 |
0.012
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
2 |
0.012
|
|
|
positive regulation of cell activation
|
GO:0050867 |
1 |
0.012
|
|
|
organelle organization
|
GO:0006996 |
227 |
0.012
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
4 |
0.012
|
|
|
regulation of chromosome segregation
|
GO:0051983 |
1 |
0.011
|
|
|
nucleobase containing compound metabolic process
|
GO:0006139 |
274 |
0.011
|
|
|
regulation of neuron migration
|
GO:2001222 |
2 |
0.011
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
39 |
0.011
|
|
|
camera type eye development
|
GO:0043010 |
222 |
0.011
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
4 |
0.011
|
|
|
septum transversum development
|
GO:0003343 |
4 |
0.011
|
|
|
pectoral fin morphogenesis
|
GO:0035138 |
29 |
0.011
|
|
|
humoral immune response mediated by circulating immunoglobulin
|
GO:0002455 |
3 |
0.011
|
|
|
positive regulation of biological process
|
GO:0048518 |
253 |
0.011
|
|
|
protein import
|
GO:0017038 |
3 |
0.011
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
2 |
0.011
|
|
|
response to amphetamine
|
GO:0001975 |
1 |
0.011
|
|
|
heart valve development
|
GO:0003170 |
14 |
0.011
|
|
|
ectodermal placode formation
|
GO:0060788 |
26 |
0.011
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
3 |
0.011
|
|
|
regulation of cell differentiation
|
GO:0045595 |
142 |
0.011
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
20 |
0.011
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
2 |
0.011
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
223 |
0.011
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
1 |
0.011
|
|
|
response to hexose
|
GO:0009746 |
3 |
0.011
|
|
|
regulation of localization
|
GO:0032879 |
104 |
0.011
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
12 |
0.011
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
22 |
0.011
|
|
|
regulation of molecular function
|
GO:0065009 |
70 |
0.011
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
46 |
0.011
|
|
|
positive regulation of secretion
|
GO:0051047 |
1 |
0.011
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
1 |
0.011
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
1 |
0.011
|
|
|
protein acylation
|
GO:0043543 |
3 |
0.011
|
|
|
neural retina development
|
GO:0003407 |
49 |
0.011
|
|
|
establishment of rna localization
|
GO:0051236 |
3 |
0.011
|
|
|
regulation of body fluid levels
|
GO:0050878 |
16 |
0.011
|
|
|
response to wounding
|
GO:0009611 |
116 |
0.010
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
16 |
0.010
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
3 |
0.010
|
|
|
heart valve morphogenesis
|
GO:0003179 |
8 |
0.010
|
|
|
regulation of bone mineralization
|
GO:0030500 |
2 |
0.010
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
3 |
0.010
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
1 |
0.010
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
2 |
0.010
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
2 |
0.010
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
4 |
0.010
|
|
|
positive regulation of cellular process
|
GO:0048522 |
201 |
0.010
|
|
|
regulation of immune system process
|
GO:0002682 |
34 |
0.010
|
|
|
positive regulation of immune system process
|
GO:0002684 |
17 |
0.010
|
|
|
response to monosaccharide
|
GO:0034284 |
3 |
0.010
|
|
|
mitotic cytokinesis
|
GO:0000281 |
3 |
0.010
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
1 |
0.010
|
|
|
endothelium development
|
GO:0003158 |
25 |
0.010
|
|
|
regulation of immune response
|
GO:0050776 |
14 |
0.010
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
1 |
0.010
|
|
|
response to oxygen containing compound
|
GO:1901700 |
55 |
0.010
|
|